TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
ANNX

Annexon Inc

Healthcare · Biotechnology

4.20$ +1.7% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Annexon Inc (ANNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 246 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANNX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
204 298 304 406 379 350 303 265 229 278 263 246
169 264 271 374 344 316 268 231 193 242 228 213
133 225 152 157 80 49 97 132 139 162 175 199
165 260 265 369 340 312 264 227 189 238 225 209
47 47 42 45 47 57 59 66 68 66 58 60
17 18 13 17 20 31 34 41 44 43 36 38
1.7 2.2 2.3 2.3 2.4 2.5 2.6 2.7 2.8 2.9 3.0 3.1
4.8 5.5 4.0 4.1 6.7 10 10 12 18 15 18 16
157 251 262 361 332 293 244 199 161 212 205 186
-545 -572 -598 -627 -662 -711 -765 -814 -869 -917 -962 -1,017
75 78 123 130 140 148 148 148 149 155 194 201

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?